Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Research Integrity

New Director for NIH Institute

by Britt E. Erickson
October 24, 2011 | A version of this story appeared in Volume 89, Issue 43

[+]Enlarge
Credit: NIGMS
Kaiser
National Institute of General Medical Sciences director-designate, Chris A. Kaiser
Credit: NIGMS
Kaiser

NIH has selected cell biologist Chris A. Kaiser to direct the National Institute of General Medical Sciences (NIGMS). Kaiser, a professor and head of the biology department at Massachusetts Institute of Technology, plans to take the helm in the spring of 2012. He replaces Acting Director Judith H. Greenberg, who has led the institute since the departure of Jeremy M. Berg last July (C&EN, June 20, page 28). The NIGMS director oversees a budget of about $2 billion; the institute supports about 4,500 grants each year and funds more chemistry-related research than any of the other 27 institutes within NIH. Kaiser is ideal for this position because of his “tremendous energy and enthusiasm for research and training—two key components of the NIGMS mission,” NIH Director Francis S. Collins said in a statement. Kaiser’s research involves the use of genetic, biochemical, and structural biology tools to unravel mechanisms of protein folding and intracellular transport. Kaiser says he is looking forward to building and sustaining a strong and diverse scientific workforce at NIGMS.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.